Regenerative technologies to bed side: Evolving the regulatory framework

There are high expectations for the clinical application of regenerative medicine technologies to treat musculoskeletal disorders. However, there are still big hurdles in bringing cell-based products to the market, mainly due to strict regulatory frameworks to approve these. Recently, the Japanese P...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Orthop Translat
Главные авторы: Sakai, Daisuke, Schol, Jordy, Foldager, Casper B., Sato, Masato, Watanabe, Masahiko
Формат: Artigo
Язык:Inglês
Опубликовано: Chinese Speaking Orthopaedic Society 2017
Предметы:
Review Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5822969/
https://ncbi.nlm.nih.gov/pubmed/29662794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jot.2017.02.001
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы